1887

Abstract

Summary

The in-vitro susceptibility to host immune defence mechanisms of Campylobacter pyloridis was investigated. was sensitive to antibodydependent complement-mediated bactericidal activity of serum. The bacteria were phagocytosed and efficiently killed by polymorphonuclear neutrophils in the presence of serum opsonins. Serum opsonin depletion studies indicated that an intact classical complement pathway was required for optimal phagocytic killing.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/00222615-23-3-233
1987-05-01
2024-04-25
Loading full text...

Full text loading...

/deliver/fulltext/jmm/23/3/medmicro-23-3-233.html?itemId=/content/journal/jmm/10.1099/00222615-23-3-233&mimeType=html&fmt=ahah

References

  1. Bienenstock J., Perey D. Y. E. 1972; Immune mechanisms of mucosal resistance. Medical Clinics of North America 56:391–402
    [Google Scholar]
  2. Bjornson A. B., Michael J. G. 1974; Factors in human serum promoting phagocytosis of Pseudomonasaeruginosa. 1. Interaction of opsonins with the bacterium. Journal of Infectious Diseases 130: Suppl S119–S126
    [Google Scholar]
  3. Blaser M. J., Duncan D. J. 1984; Human serum antibody response to Campylobacterjejuni infection as measured in an enzyme-linked immunosorbent assay. Infection and Immunity 44:292–298
    [Google Scholar]
  4. Eldridge J., Lessells A. M., Jones D. M. 1984; Antibody to spiral organisms on gastric mucosa. Lancet 1:12–37
    [Google Scholar]
  5. Fierer J., Finley F., Braude A. I. 1972; A plaque assay on agar for detection of gram-negative bacilli sensitive to complement. Journal of Immunology 109:1156–1158
    [Google Scholar]
  6. Fine D. P., Marney S. R., Colley D. G., Sergent J. S., DesPrez R. M. 1972; C3 shunt activation in human serum chelated with EGTA. Journal of Immunology 109:807–809
    [Google Scholar]
  7. Götze O., Eberhard H. J. 1971; The C3-activator system: an alternate pathway of complement activation. Journal of Experimental Medicine 134:90s–108s
    [Google Scholar]
  8. Guckian J. C., Christensen W. D., Fine D. P. 1978; Evidence for quantitative variability of bacterial opsonic requirements. Infection and Immunity 19:822–826
    [Google Scholar]
  9. Hill R., Pearman J., Worthy P., Caruso V., Goodwin S., Blincow E. 1986; Campylobacterpyloridis and gastritis in children. Lancet 1:387
    [Google Scholar]
  10. International Journal of Systematic Bacteriology 1985; Validation of the publication of new names and new combinations previously, effectively, published outside the IJBS. List no.17.. International Journal of Systematic Bacteriology 85:223–225
    [Google Scholar]
  11. Johnston R. B., Baehner R. L. 1971; Chronic granulomatous disease: correlation between pathogenesis and clinical findings. Pediatrics 48:730–739
    [Google Scholar]
  12. Jones D. M., Lessells A. M., Eldridge J. 1984; Campylobacter like organisms on the gastric mucosa: culture, histological, and serological studies. JournalofClinicalPathology 37:1002–1006
    [Google Scholar]
  13. Kaplan E. L., Laxdal T., Quie P. G. 1968; Studies of polymorphonuclear leukocytes from patients with chronic granulomatous disease of childhood: bactericidal capacity for streptococci. Pediatrics 41:591–599
    [Google Scholar]
  14. Langenberg M. L., Tytgat G. N. J., Schipper M. E. I., RietraP J. G. M., Zanen H. C. 1984; Campylobacter-like organisms in the stomach of patients and healthy individuals. Lancet 1:1348
    [Google Scholar]
  15. Marshall B. J., Warren J. R. 1984; Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1:1311–1315
    [Google Scholar]
  16. Marshall B. J., McGechie D. B., Rogers P. A., Glancy R. J. 1985a; Pyloric Campylobacter infection and gastroduodenal disease. MedicalJournalofAustralia 142:439–444
    [Google Scholar]
  17. Marshall B. J., Armstrong J. A., McGechie D. B., Glancy R. J. 1985b; Attempts to fulfil Koch’s postulates for pyloric Campylobacter. MedicalJournalofAustralia 142:436–439
    [Google Scholar]
  18. Newman S. L., Waldo B., Johnston R. B. 1973; Separation of serum bactericidal and opsonizing activities for Haemophilusinfluenzae Type b. InfectionandImmunity 8:488–490
    [Google Scholar]
  19. Phillips A. D., Hine K. R., Holmes G. K. T., Woodings D. F. 1984; Gastric spiral bacteria. Lancet 2:100–101
    [Google Scholar]
  20. Platts-Mills T. A. E., Ishizaka K. 1974; Activation of the alternate pathway of human complement by rabbit cells. Journal of Immunology 113:348–358
    [Google Scholar]
  21. Rollason J. P., Stone J., Rhodes J. M. 1984; Spiral organisms in endoscopic biopsies of the human stomach. Journal of Clinical Pathology 37:23–26
    [Google Scholar]
  22. Rowley D. 1954; The virulence of strains of Bacteriumcoli for mice. British Journal of Experimental Pathology 35:528–538
    [Google Scholar]
  23. Shousha S., Bull T. B., Parkins R. A. 1984; Gastric spiral bacteria. Lancet 2:101
    [Google Scholar]
  24. Verbrugh H. A., VanDijk W. C., Peters R., DerTol M. E., Peterson P. K., Verhoef J. 1979; Staphylococcusaureus opsonization mediated via the classical and alternate complement pathways. A kinetic study using Mg EGTA chelated serum and human sera deficient in IgG and complement factors CIs and C2. Immunology 36:391–397
    [Google Scholar]
  25. Warren J. R. 1983; Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet 1:1273
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/00222615-23-3-233
Loading
/content/journal/jmm/10.1099/00222615-23-3-233
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error